May 18, 2024

Brave girl of 13 beats leukaemia in world-first clinical trial 

Alyssa had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained. She then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street.Alyssa had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained. She then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street.Read MoreHealth News | Mail Online

Leave a Reply

Your email address will not be published. Required fields are marked *